Navigation Links
New Jersey Health Foundation Awards First Two Innovation Stage Funding Grants
Date:1/23/2013

NEW BRUNSWICK, N.J., Jan. 23, 2013 /PRNewswire-USNewswire/ -- Dr. Tomer Davidov and Dr. William C. Gause are the first two recipients of grants from New Jersey Health Foundation's Innovation Stage Funding Program to advance their medical research that could eventually be commercialized for consumer benefit.

Dr. Davidov, an assistant professor of surgery at Robert Wood Johnson Medical School in New Brunswick, is developing a novel puncture resistant surgical glove that will offer healthcare professionals the highest level of needle stick protection without compromising tactile sensation and manual dexterity.

"Needle-stick injury is a common problem among healthcare professions, with 4 million estimated injuries annually in the United States," Dr. Davidov said.  "One study in the New England Journal of Medicine found that a staggering 99% of surgeons reported a needle stick injury during their training alone, 53% of which were with high risk patients.  It is no wonder that 96% of surveyed surgeons are concerned about contracting HIV or Hepatitis C as a result of needle stick injuries."

According to Dr. Davidov, current tear resistant gloves use thicker standard material, but do not provide true needle stick puncture protection.  He will use the grant from the Innovation Stage Funding Program to develop the prototype for a surgical glove that uses a novel manufacturing process and a newly developed puncture resistant, flexible, paper-thin material.

Dr. Gause, the senior associate dean for research at New Jersey Medical School in Newark, has developed a new approach to enhance the treatment of wound healing using compositions derived from metazoan parasites at the site of an injury.  His grant will be used to further develop a potential commercial product.

"Chronic wounds represent a significant burden to patients, healthcare professionals and the U.S. health care system, affecting 5.7 million patients and costing an estimated 20 billion dollars annually," said Dr. Gause.  "Our research to date shows that the characteristic type of immune response triggered by macroparasites has active components that can enhance tissue repair and wound healing."

Through the Innovation Stage Funding Program, New Jersey Health Foundation has allocated $500,000 to provide grants from $10,000 up to $50,000 each to researchers with promising ideas to advance an intellectual property toward commercialization through a start-up.  At the current time, researchers with these objectives affiliated with the University of Medicine and Dentistry of New Jersey (UMDNJ) are able to apply for funding.

For more information and to check eligibility, visit the What's New section at www.foundationofumdnj.org.  

About New Jersey Health Foundation

New Jersey Health Foundation (www.njhf.org,) established in 2002 as a not-for-profit public charity, is the parent company to the Foundation of UMDNJ (www.foundationofumdnj.org) and The Foundation for Healthcare Advancement (www.foundationforhealthcareadvancement.org), which solicit private sector support for the University of Medicine and Dentistry of New Jersey and to Foundation Venture Capital Group, LLC,  (www.foundationventure.com) which makes private equity investments in start-up technology companies founded by researchers affiliated with the University.


'/>"/>
SOURCE New Jersey Health Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
2. Eisai USA Foundation to Donate $100,000 to the Hurricane Sandy New Jersey Relief Fund, $50,000 to the American Red Cross
3. New Jersey Lawsuit About the Dietary Supplement Relacore Certified to Proceed As a Class Action
4. New Jersey Health Foundation Commits $2 Million to Fund Grants
5. In Observance of Veterans Day Reproductive Medicine Associates of New Jersey Extends "Helping Heroes Build Families" Program
6. New Jersey Health Foundation Initiates Program To Spur Innovative Research
7. Prostate Cancer Center of New Jersey the Latest Center to Achieve High Honor of ACR-ASTRO Accreditation
8. Clinilabs Opens Phase I Unit In Eatontown, New Jersey
9. New Jersey Ophthamologist Now Offers Pelleve Wrinkle Reduction Treatment
10. Dr. Phillip Chan Named Finalist for Ernst & Young Entrepreneur of the Year® 2012 Award in New Jersey
11. Global Pharmaceutical Leaders All Converging in Parsippany, New Jersey on September 11-12, 2012 for Breakthrough Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017  Levine Cancer Institute ... (CT) unit designed to address lung cancer diagnosis, ... the Carolinas. The mobile lung unit is the ... education and treatment interventions through integrated mobile technology, ... Financial barriers and a lack of public ...
(Date:3/22/2017)... 2017 MarketNewsUpdates.com News Commentary  ... ... CBD oil continues to rise in popularity with consumers, ... are enhancing production through acquiring innovative assets and other ... sector include: Future Farm Technologies Inc (OTC: FFRMF) (CSE: FFT.CN), ...
(Date:3/22/2017)... , March 22, 2017  Varex Imaging Corporation ... entered into a renewed three-year pricing agreement with Toshiba ... supply its computed tomography (CT) tubes for integration into ... This renewed agreement will be effective April 1, 2017. ... this renewed agreement are estimated to be in the ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... March 22, 2017 , ... The American Society for ... (PA) form for prescribers to improve patients’ access to the revolutionary therapy for ... as part of the article entitled “PCSK9 Inhibitor Access Barriers: Issues and ...
(Date:3/22/2017)... Georgia (PRWEB) , ... March 22, 2017 , ... ... time consuming and frustrating and this tool bypasses that. Healthcare facilities across ... identified an opportunity to offer their clients and hospitals, across the country, an ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... the nation’s leading digital and print media enterprise focused on cancer patients, cancer ... content, has released a special 12-part educational video series, “No Ifs, Ands, or ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... solution provider, today announced that its digital marketing solutions have enabled Children’s Hospital ... investment in 24 months. , Recognizing the value of a digital marketing ...
(Date:3/22/2017)... ... 2017 , ... An intensive search of the medical literature has revealed no ... PhD. He says investigating this possibility, is important because Miami-Dade in 2016 ... infections with HIV. , His findings appear on Analizir.com. . Dr. ...
Breaking Medicine News(10 mins):